Whereas, a greater rate of BRCA1/2 germline variants was reported in familial breast cancer patients from Lebanon (15.5%) [50], and Egypt (19.8% for BRCA1 and 30.6% for BRCA2) [33]. This evidence concerns the gene BRCA1 and breast cancer.